OHSU Knight Cancer Institute — Portland, Oregon

Which of these are you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of OHSU Knight Cancer Institute, compiled from the ClinicalTrials.gov public registry.

251

Registered studies

Active

Recruiting now

100

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Carcinoma, Non-Small-Cell Lung · Advanced Malignant Solid Neoplasm · High-grade B-cell Lymphoma (HGBCL)

Recently updated registry entries

NCT04104139 — TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III… (Completed)
NCT03625037 — First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell… (Active Not Recruiting)
NCT05963074 — A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously… (Active Not Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.